These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15254661)

  • 1. Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients.
    Celen O; Kahraman I; Yildirim E; Berberoglu U
    Neoplasma; 2004; 51(4):293-9. PubMed ID: 15254661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
    Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
    Fan YZ; Li GM; Huang GP; Li XP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer.
    Ferroni P; Palmirotta R; Spila A; Martini F; Formica V; Portarena I; Del Monte G; Buonomo O; Roselli M; Guadagni F
    Oncology; 2006; 71(3-4):176-84. PubMed ID: 17652942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma.
    Uner A; Ebinc FA; Akyurek N; Unsal D; Mentes BB; Dursun A
    Exp Oncol; 2005 Sep; 27(3):225-8. PubMed ID: 16244586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 20 and vascular endothelial growth factor as molecular markers in Egyptian patients with colorectal cancer.
    Auf FA; El-Eibdy GK; Mosaad YM; El-Ghannam DM; El-Masry EE
    J Oncol Pharm Pract; 2011 Sep; 17(3):160-7. PubMed ID: 20395351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis.
    Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Kuramochi H; Lenz HJ; Danenberg KD; Danenberg PV
    Ann Surg Oncol; 2008 Apr; 15(4):1232-8. PubMed ID: 18239970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer.
    Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallböhmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV
    Clin Cancer Res; 2006 Jan; 12(1):29-33. PubMed ID: 16397020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
    Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
    Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T; Okada N; Nakada H; Yokoyama M; Miyazaki T; Ishibashi K; Ishida H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma].
    Broll R; Erdmann H; Windhövel U; Duchrow M; Strik MW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):315-8. PubMed ID: 14518267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The evaluation to relationship between serum vascular endothelial growth factor (VEGF) level, metastases and other tumor markers in patients with lung cancer].
    Sağlam DA; Ursavaş A; Karadağ M; Yilmaztepe Oral A; Coşkun F; Gözü RO
    Tuberk Toraks; 2008; 56(1):50-5. PubMed ID: 18330755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor concentrations in the plasma-activated platelets rich (P-APR) of healthy controls and colorectal cancer patients.
    Ranieri G; Coviello M; Patruno R; Valerio P; Martino D; Milella P; Catalano V; Scotto F; De Ceglie A; Quaranta M; Ribatti D; Pellecchia A
    Oncol Rep; 2004 Oct; 12(4):817-20. PubMed ID: 15375505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of postoperative serum vascular endothelial growth factor (VEGF)--can it be used to predict curative resections in colorectal cancer?
    Kumar H; Heer K; Duthie GS; Monson JR
    Anticancer Res; 2002; 22(6B):3717-22. PubMed ID: 12552982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.